Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-05

FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)

View source ↗

Summary

FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, confirming the generic product's approval under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorpromazine HCl (chlorpromazine hydrochloride)

Snippet

SUPPL AP for CHLORPROMAZINE HCI (CHLORPROMAZINE HCI)